🔎 Trials Near Me

Home › Cancro metastatico › Georgia › Atlanta

Studi clinici su Cancro metastatico a Atlanta, GA

28 studi su Cancro metastatico cercano partecipanti presso sedi a Atlanta e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

In reclutamentoFase 3
  • Piedmont Cancer Institute, Atlanta
  • Piedmont Healthcare, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT07562152

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

In reclutamentoFase 1
  • Winship Cancer Institute of Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

In reclutamentoFase 1
  • Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

In reclutamentoFase 1
  • Emory Winship Cancer Institute, Atlanta
Età 19 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06586957

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

In reclutamentoFase 1/2
  • Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
Fino a 25 anni · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04094610

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

In reclutamentoFase 1
  • Emory Winship Cancer Institute, Atlanta
Età 18 e oltre · Uomini · Aggiornato il 24 set 2026 · NCT07543055

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

In reclutamentoFase 1
  • Emory University School of Medicine - Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

In reclutamentoFase 3
  • Winship Cancer Institute, Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

In reclutamentoFase 3
  • Emory University School of Medicine- Grady Campus, Atlanta
  • Winship Cancer Institute, Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

In reclutamentoFase 1
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT04585958

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

In reclutamentoFase 1/2
  • Avenzo Therapeutics Recruiting Site, Atlanta
Età da 18 a 75 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07038343

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

In reclutamentoFase 3
  • Winship Cancer Institute of Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06072612

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

In reclutamentoFase 2
  • Emory University School of Medicine, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

In reclutamentoFase 1
  • Emory University Hospital, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05614739

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

In reclutamentoFase 1/2
  • Crinetics Study Site, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 lug 2026 · NCT07129252

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

In reclutamentoFase 1
  • Winship Cancer Center - Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 lug 2026 · NCT06657144

A Study of PYX-201 in Advanced Solid Tumors

In reclutamentoFase 1
  • Winship Cancer Institute, Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 giu 2026 · NCT05720117

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

In reclutamentoFase 1/2
  • Winship Cancer Institute, Emory University, Atlanta
Età 12 e oltre · Tutti i sessi · Aggiornato il 27 mag 2026 · NCT05384626

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

In reclutamentoFase 1
  • Winship Cancer Institute at Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT07094204

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

In reclutamentoFase 1/2
  • Piedmont Healthcare, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 mag 2026 · NCT05379985

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

In reclutamentoFase 3
  • Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06064877

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

In reclutamentoFase 2/3
  • Emory Winship Cancer Institute, Atlanta
Tutte le età · Tutti i sessi · Aggiornato il 2 apr 2026 · NCT06581406

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

In reclutamentoFase 1/2
  • Emory Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 apr 2026 · NCT05735080

Venetoclax Basket Trial for High Risk Hematologic Malignancies

In reclutamentoFase 1
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Età da 1 a 40 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT05292664

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

In reclutamentoFase 3
  • Emory Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 feb 2026 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

In reclutamentoStudio osservazionale
  • Massive Bio SYNERGY-AI site, Atlanta
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

In reclutamentoFase 1 iniziale
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2025 · NCT06328686

A Beta-only IL-2 ImmunoTherapY Study

In reclutamentoFase 1/2
  • Emory - Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2025 · NCT05086692

Studi su Cancro metastatico in altre città

Altri studi a Atlanta

Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.